Optimising GLP-1/GIP targeting for individual patients We are currently working to clarify how exactly each receptor works by investigating how they move across the cells of the pancreas, the signals they send, and the partners they interact with
Endocrine Reviews, 43(5), 763793
Although some patients reach their plateau earlier, it can take over a year for the drug to reach full effectiveness
Maintaining the same caloric deficit you had on tirzepatide without accounting for the additional expenditure can push you into an excessive deficit that promotes muscle loss, fatigue, and metabolic adaptation
More than medication You are not just getting medication
Summary: Stacking retatrutide and tesamorelin is not supported by any clinical evidence, carries significant safety risks, and involves two agents that are unlicensed in the UK